XAGRID® (anagrelide hydrochloride)
This product is registered in numerous countries throughout the world. If information relevant to your country is not available on this page, please consult your local physician.
This product is licensed in the following countries:
Austria
Belgium
Bulgaria
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany (local website)
Greece
Hungary
Iceland
Ireland
Italy (local website)
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland (local website)
Portugal
Romania
Slovakia
Slovenia
Spain (local website)
Sweden
Switzerland (local website)
United Kingdom
Our global reach
Our products are marketed in over 50 countries worldwide, and we now have offices in over 27 countries. View our interactive map, and learn more
about our global reach.
